structural basis type ii topoisomerase inhibition anticancer drug etoposide
type ii topoisomerases top2s resolve topological problems dna transiently cleaving strands dna duplex form cleavage complex another dna segment can transported several widely prescribed anticancer drugs increase population top2 cleavage complex leads top2-mediated chromosome dna breakage death cancer cells present crystal structure large fragment human top2 beta complexed dna anticancer drug etoposide reveal structural details drug-induced stabilization cleavage complex interplay protein dna drug explains structure-activity relations etoposide derivatives molecular basis drug-resistant mutations analysis protein-drug interactions provides information applicable developing isoform-specific top2-targeting strategy
